Study by Humana Healthcare Research and Yale School of Medicine researcher reveals significant increase in CGM usage, particularly among older adults with chronic health conditions. The study also ...
Claims data reveal larger hemoglobin A1c decreases in people with type 2 diabetes who use continuous glucose monitoring and semaglutide compared with semaglutide alone. Study Design: Using US health ...
(Boston)—With the Food and Drug Administration now allowing for the over-the-counter purchase of continuous glucose monitor (CGM)—small sensors that penetrate the skin to measure glucose levels in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results